Researchers in the OHSU Digestive Health Center are developing a system through which clinicians hope to more easily identify people at increased risk for the disease. Early identification allows physicians to identify malignancies sooner and begin aggressive treatment quicker. Only patients at high risk for pancreatic cancer will be monitored.
The good news for NFL players who sustain an injury to their anterior cruciate ligament (ACL) is that they’ll likely play again in the NFL. The bad news is, they’ll return with diminished performance on the field, concludes a study in the December issue of The American Journal of Sports Medicine.
A University of Manchester researcher has developed a treatment for lower back pain using the patient’s own stem cells, which could replace the use of strong painkillers or surgery that can cause debilitation, neither of which addresses the underlying cause.
A new study examined muscle strength, performance and outcomes perceived by patients several years after undergoing a meniscectomy.
More than half of breast cancer patients who sought a second opinion from a multidisciplinary tumor board received a change in their recommended treatment plan, according to a new study from the University of Michigan Comprehensive Cancer Center.
German researchers found using a minimally invasive technique to correct blocked vessels in the testicles i.e. varicoceles, one of the commonest causes of male infertility can increase the chances of fathering a child. The findings were presented at the annual meeting of the Radiological Society of North America.
The HeptoVax trial is a phase II trial evaluating the safety and efficacy of GV1001 in advanced hepatocellular carcinoma (“HCC” or “liver cancer”). The trial will enrol patients from three centres in Spain, France and Germany.
Phase II clinical trial results published today in Circulation (2006;114:2374-2381) highlight the potential of a simple, once-daily dosing regimen of the novel, oral anticoagulant rivaroxaban (BAY 59-7939), a direct Factor Xa inhibitor. In this trial, rivaroxaban demonstrated that it may have similar safety and efficacy to subcutaneous enoxaparin (the current standard), for the prevention of venous thromboembolism (VTE) in patients undergoing elective total hip replacement surgery.
Georgia Tech and Emory University researchers have developed an innovative new technology that will help pediatric cardiac surgeons design and test a customized surgical procedure before they ever pick up a scalpel.
Implanting a small spacer between lumbar vertebrae during a procedure called interspinous process decompression may be an effective and minimally invasive way to treat spinal stenosis, according to a new report.